|
시장보고서
상품코드
2040565
일회용 바이오프로세싱 커넥터 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)Single-use Bioprocessing Connectors Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
일회용 바이오프로세싱 커넥터 시장 현황 요약
세계의 일회용 바이오프로세싱 커넥터 시장 규모는 2025년에 14억 달러로 평가되었으며, 2033년까지 42억 달러에 달할 것으로 예상되고, 2026년부터 2033년까지 CAGR 14.1%로 성장할 전망입니다.
이러한 성장은 일회용 바이오프로세싱 시스템의 채택 확대, 바이오의약품 및 바이오시밀러 생산 증가, 커넥터 설계 및 기능의 지속적인 발전 등에 힘입어 성장세를 보이고 있습니다.
오염 위험 감소와 운영 효율성 향상에 대한 관심이 높아지고 있습니다. 일회용 바이오프로세싱 커넥터의 진화는 설계, 재료, 자동화의 발전에 힘입어 바이오의약품 제조의 무균성, 효율성, 확장성을 향상시키고 있습니다. 고급 무균 커넥터는 오염을 방지하기 위해 이중 무균 장벽, 일체형 씰 및 자동 폐쇄 메커니즘을 갖추고 있습니다. 또한, 이러한 고급 제품은 남녀 구분이 필요 없는 젠더리스 디자인을 채택하여 조립을 단순화하고 인적 오류를 줄입니다. 예를 들어, 2023년 4월, Colder Products Company는 무균 커넥터 'AseptiQuik W 시리즈'의 출시를 발표했습니다. 이 커넥터는 업계 최대 규모의 젠더리스 무균 커넥터로 주목받고 있으며, 1.5인치의 유로를 갖추고 있어 분당 수백 리터의 이송이 가능합니다. 이는 바이오 공정에서 유체 이송 시간을 대폭 단축하는 것을 목표로 하고 있습니다. 이러한 기술 발전은 일회용 시스템 도입 확대와 바이오의약품 및 바이오시밀러 생산 증가에 따른 전체 시장의 성장과 밀접하게 연관되어 있습니다. 바이오의약품 공정이 복잡해짐에 따라 신뢰할 수 있고, 무균적이며, 확장 가능한 유체 이송 솔루션에 대한 수요가 증가하고 있습니다. 고급 커넥터 시스템은 폐쇄형 시스템에서 처리할 수 있도록 하는 데 중요한 역할을 하며, 이를 통해 업무 효율성을 향상시키고 엄격한 규제 기준을 준수할 수 있도록 합니다.
또한, 바이오 제약 산업의 급속한 확장은 시장 수요를 지속적으로 증가시키고 있습니다. 2024년, FDA는 총 50개의 새로운 치료제를 승인했습니다. 그 중에는 10종의 단클론항체와 3종의 이중특이성항체가 포함되어 있으며, 단백질 의약품의 승인 건수에서 큰 비중을 차지했습니다. 단클론항체 및 첨단 치료법에 대한 관심이 높아짐에 따라 무균 유체 이송용 커넥터를 포함한 일회용 기술에 대한 요구가 가속화되고 있습니다. 예를 들어, Merck KGaA가 제공하는 Lynx CDR 커넥터는 대규모 단클론항체 생산에서 효율적인 대량 유체 이송을 위해 특별히 설계되어 첨단 바이오프로세스 솔루션의 도입을 더욱 촉진하고 있습니다.
또한, 바이오의약품의 제조를 위탁개발생산기관(CDMO)에 아웃소싱하는 사례가 증가하고 있습니다. 이러한 시설에서는 여러 고객 및 제품에 대응하기 위해 높은 유연성과 확장성을 갖춘 생산 시스템이 필요하며, 일회용 기술이 이상적인 솔루션이 될 수 있습니다. 일회용 커넥터는 전환 시간 단축, 교차 오염 위험 감소 및 효율적인 다품종 생산이 가능합니다. 따라서 CDMO에 대한 의존도가 높아짐에 따라 업계 전반에 걸쳐 일회용 바이오프로세싱 커넥터의 도입이 더욱 가속화되고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 시장 : 변수, 동향, 범위
제4장 제품별 비즈니스 분석
제5장 용도별 비즈니스 분석
제6장 최종 용도별 비즈니스 분석
제7장 지역별 비즈니스 분석
제8장 경쟁 구도
KSM 26.06.04Single-use Bioprocessing Connectors Market Summary
The global single-use bioprocessing connectors market size was valued at USD 1.4 billion in 2025 and is expected to reach USD 4.2 billion by 2033, growing at a CAGR of 14.1% from 2026 to 2033. This growth is driven by the increasing adoption of single-use bioprocessing systems, the rising production of biologics and biosimilar, and continuous advancements in connector design and functionality.
Growing emphasis on reducing contamination risks and improving operational efficiency. The evolution of single-use bioprocessing connectors has been driven by advancements in design, materials, and automation, enhancing sterility, efficiency, and scalability in biopharmaceutical manufacturing. Advanced aseptic connectors feature double sterile barriers, integrated seals, and self-closing mechanisms to prevent contamination. The advanced products also feature genderless designs that eliminate the need for male/female configurations, simplifying assembly and reducing human error. For instance, in April 2023, Colder Products Company announced the launch of its AseptiQuik W Series aseptic connectors. These connectors are notable for being the industry's largest genderless aseptic connectors, featuring a 1-1/2-inch flow path that facilitates the transfer of hundreds of liters per minute. This is aimed at significantly reducing fluid transfer times in bioprocesses. These technological advancements align closely with the broader market growth, which is driven by the increasing adoption of single-use systems and the rising production of biologics and biosimilar. The growing complexity of biopharmaceutical processes has intensified the demand for reliable, sterile, and scalable fluid transfer solutions. Advanced connector systems play a critical role in enabling closed-system processing, thereby enhancing operational efficiency and ensuring compliance with stringent regulatory standards.
Moreover, the rapid expansion of the biopharmaceutical industry continues to reinforce market demand. In 2024, a total of 50 new therapeutics were approved by the FDA, including 10 monoclonal antibodies and 3 bispecific antibodies, which together accounted for a significant share of protein-based drug approvals. The increasing focus on monoclonal antibodies and advanced therapies has accelerated the need for single-use technologies, including connectors for aseptic fluid transfer. For instance, Lynx CDR connectors offered by Merck KGaA are specifically designed for efficient bulk fluid transfer in large-scale monoclonal antibody production, further supporting the adoption of advanced bioprocessing solutions.
In addition, increasing outsourcing of biopharmaceutical manufacturing to contract development and manufacturing organizations (CDMOs). These facilities require highly flexible and scalable production systems to accommodate multiple clients and products, making single-use technologies an ideal solution. Single-use connectors enable faster changeovers, reduce the risk of cross-contamination, and support efficient multi-product operations. So, the growing reliance on CDMOs is further accelerating the adoption of single-use bioprocessing connectors across the industry.
Global Single-use Bioprocessing Connectors Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and analyzes the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global single-use bioprocessing connectors market by product, application, end-use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Aseptic Connectors
- Conventional Connectors
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Upstream Bioprocessing
- Downstream Bioprocessing
- Fill-finish Operations
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Biopharmaceutical & Pharmaceutical Companies
- OEMs
- CROs & CMOs
- Academic & Research Institutes
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Regional Scope
- 1.4. Estimates and Forecast Timeline
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Primary Research
- 1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Secondary Sources
- 1.11. List of Abbreviations
- 1.12. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing adoption of single-use technologies in the biopharmaceutical industry
- 3.2.1.2. Technological Innovation in Connector Designs
- 3.2.1.3. Growing biologics market
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Regulatory concerns over leachable & extractables
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Single-use Bioprocessing Connectors Market: Product Movement Analysis
- 4.3. Single-use Bioprocessing Connectors Market Size & Trend Analysis, By Product, 2021 to 2033 (USD Million)
- 4.4. Aseptic Connectors
- 4.4.1. Aseptic Connectors Market, 2021 - 2033 (USD Million)
- 4.5. Conventional Connectors
- 4.5.1. Conventional Connectors Market, 2021 - 2033 (USD Million)
Chapter 5. Application Business Analysis
- 5.1. Single-use Bioprocessing Connectors Market: Application Movement Analysis
- 5.2. Upstream Bioprocessing
- 5.2.1. Upstream Bioprocessing Market, 2021 - 2033 (USD Million)
- 5.3. Downstream Bioprocessing
- 5.3.1. Downstream Bioprocessing Market, 2021 - 2033 (USD Million)
- 5.4. Fill-finish Operations
- 5.4.1. Fill-finish Operations Market, 2021 - 2033 (USD Million)
Chapter 6. End-use Business Analysis
- 6.1. Single-use Bioprocessing Connectors Market: End-use Movement Analysis
- 6.2. Biopharmaceutical & Pharmaceutical Companies
- 6.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
- 6.3. OEMs
- 6.3.1. OEMs Market, 2021 - 2033 (USD Million)
- 6.4. CROs & CMOs
- 6.4.1. CROs & CMOs Market, 2021 - 2033 (USD Million)
- 6.5. Academic & Research Institutes
- 6.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Single-use Bioprocessing Connectors Market Share By Region, 2025 & 2033
- 7.2. North America
- 7.2.1. North America Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. U.S. Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Canada Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Competitive Scenario
- 7.2.4.3. Regulatory Framework
- 7.2.4.4. Mexico Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. UK Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Germany Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. France Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Italy Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Spain Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Competitive Scenario
- 7.3.7.3. Regulatory Framework
- 7.3.7.4. Denmark Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Competitive Scenario
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Sweden Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Competitive Scenario
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Norway Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Japan Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. China Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. India Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.4.5. Australia
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Australia Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.4.6. Thailand
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Thailand Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.4.7. South Korea
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. South Korea Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Brazil Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Argentina Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.6. MEA
- 7.6.1. MEA Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. South Africa Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Saudi Arabia Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. UAE Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Kuwait Single-use Bioprocessing Connectors Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Position Analysis, 2025
- 8.4. Company Profiles
- 8.4.1. Sartorius AG
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Merck KGaA
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Danaher
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Saint-Gobain Life Sciences
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Colder Products Company
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Thermo Fisher Scientific Inc.
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Avantor Inc.
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Repligen Corporation
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Entegris Inc.
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Watson-Marlow Fluid Technology Solutions
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.11. Foxx Life Sciences
- 8.4.11.1. Overview
- 8.4.11.2. Financial Performance
- 8.4.11.3. Product Benchmarking
- 8.4.11.4. Strategic Initiatives
- 8.4.12. Nordson Corporation
- 8.4.12.1. Overview
- 8.4.12.2. Financial Performance
- 8.4.12.3. Product Benchmarking
- 8.4.12.4. Strategic Initiatives
- 8.4.1. Sartorius AG
